Logo
Home Study Material Contact Search
AI Chat FREE
  1. business
  2. accounting
  3. following are the individual financial statements

Following are the individual financial statements for Gibson and Davis for the year ending December...

60.1K

Verified Solution

Question

Accounting

Following are the individual financial statements for Gibson and Davis for the year ending December 31, 2021: Gibson Davis Sales $ (718,000 ) $ (355,000 ) Cost of goods sold 332,000 150,000 Operating expenses 214,000 75,000 Dividend income (24,000 ) 0 Net income $ (196,000 ) $ (130,000 ) Retained earnings, 1/1/21 $ (705,000 ) $ (410,000 ) Net income (196,000 ) (130,000 ) Dividends declared 60,000 40,000 Retained earnings, 12/31/21 $ (841,000 ) $ (500,000 ) Cash and receivables $ 228,500 $ 133,000 Inventory 504,000 137,000 Investment in Davis 511,500 0 Buildings (net) 538,000 610,000 Equipment (net) 494,000 494,000 Total assets $ 2,276,000 $ 1,374,000 Liabilities $ (805,000 ) $ (534,000 ) Common stock (630,000 ) (340,000 ) Retained earnings, 12/31/21 (841,000 ) (500,000 ) Total liabilities and stockholders' equity $ (2,276,000 ) $ (1,374,000 ) Gibson acquired 60 percent of Davis on April 1, 2021, for $511,500. On that date, equipment owned by Davis (with a five-year remaining life) was overvalued by $75,000. Also on that date, the fair value of the 40 percent noncontrolling interest was $341,000. Davis earned income evenly during the year but declared the $40,000 dividend on November 1, 2021.

Answer & Explanation Solved by verified expert
Get Answers to Unlimited Questions

Join us to gain access to millions of questions and expert answers. Enjoy exclusive benefits tailored just for you!

Membership Benefits:
  • Unlimited Question Access with detailed Answers
  • Zin AI - 3 Million Words
  • 10 Dall-E 3 Images
  • 20 Plot Generations
  • Conversation with Dialogue Memory
  • No Ads, Ever!
  • Access to Our Best AI Platform: Flex AI - Your personal assistant for all your inquiries!
Become a Member

Other questions asked by students